Attorneys at Sidley Austin LLP examine the issue of drug price reporting rules under Medicaid and enforcement risks under the False Claims Act.
CMS recently announced the next 15 drugs that will be subject to price negotiations under the Inflation Reduction Act of 2022 (IRA). These are negotiations in name only because CMS can levy penalties ...
Hosted on MSN
CMS Unveils ‘GENEROUS’ Drug Payment Model To Secure Lower Medicaid Prescription Costs
The Centers for Medicare & Medicaid Services (CMS) today announced a landmark initiative, the GENErating cost Reductions fOr U.S. (GENEROUS) Medicaid Model, aimed at significantly lowering ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results